Exane BNP Paribas Downgrades Novartis (NVS) to Neutral
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $156.24 --0%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Exane BNP Paribas downgraded Novartis (NYSE: NVS) from Outperform to Neutral.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $56.37 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $56.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce
- JPMorgan Downgrades Bowman Consulting Group Ltd. (BWMN) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
